Topic
History of Medical Botany
Medical botany is the history of how plants became identifiable,
cultivable, and teachable objects of medical knowledge. It runs from
Theophrastus's plant descriptions in Athens around 300 BCE, through
Dioscorides's De materia medica, the physic gardens of Renaissance
Italy, Linnaeus's binomial naming in 1753, and the colonial collecting
networks of the eighteenth century, to the laboratory pharmacology that
turned foxglove, willow, cinchona, and sweet wormwood into measured drugs.
The history of medical botany is not only a history of useful plants. It is
a history of how living specimens were collected, drawn, cultivated,
standardized, and translated into claims about cure, toxicity, evidence,
and authority — and of who was credited when that knowledge moved across
languages, empires, and institutions.
- Scope
- Ancient plant science, materia medica, physic gardens, botanical illustration, taxonomy, colonial collecting, plant-derived drugs, and pharmacology
- Key themes
- Identification, cultivation, illustration, extraction, empire, commerce, dosage, toxicity, and the boundary between botany and medicine
- Search focus
- History of medical botany, medicinal plants, physic gardens, botanical medicine, and plant drugs history
Classical Foundations
Classical botany made plants describable, but names kept drifting
Plants entered medicine through gathering, taste, household practice,
trade, and garden culture. Botany became medical when accurate
identification mattered for safety, supply, and therapeutic credibility.
The classical tradition supplied the first systematic attempt to make that
identification reliable.
The starting point in the Western tradition is Theophrastus, a student of
Aristotle who directed the Lyceum's garden in Athens. His
Historia Plantarum (c. 300 BCE, in ten books) described hundreds
of plants by their parts, habitats, and uses, and it remained the standard
reference for plant description for over a millennium. A century later,
the Greek physician Pedanius Dioscorides wrote De materia medica
(c. 78 CE) in five books describing some 600 plants, their preparations,
and their uses. The same remedy could move through many settings —
kitchen, monastery, marketplace, apothecary shop, hospital, ship, and
garden — and the wider
history of herbal medicine
supplies the practical background for that tradition.
Both works were transmitted as texts, and that created a persistent
problem. A reader in sixth-century Rome or twelfth-century Baghdad had to
match a Greek or Arabic name to a living plant without seeing the original
specimen. Local names, look-alike species, dried samples, and commercial
substitution meant that the same name could refer to different plants in
different regions, and the same plant could carry many names. Later
botanists treated this drift of names as a medical hazard, not merely a
scholarly curiosity: a misidentified plant could poison a patient or
defeat a prescription.
Empire And Exchange
Colonial collecting moved plants, knowledge, and credit
European empires treated plants as strategic resources. Botanical gardens,
colonial officials, missionaries, physicians, merchants, enslaved people,
Indigenous experts, and local healers all contributed to the movement of
medicinal plant knowledge, though credit and profit were unevenly assigned.
The twelve-volume Hortus Indicus Malabaricus (1678–1693),
produced under Dutch East India Company patronage in Malabar, shows the
form this took: plants were cultivated, described, and painted by local
artists and scholars under colonial direction, and the finished work
circulated in Europe as Dutch science. Cinchona is the clearest case of
a plant drug moving through empire. The bark of Andean cinchona trees,
used locally for fevers, reached Europe in the 1630s through Jesuit
missionaries and was sold as "Jesuit's bark." The story that it was first
given to the Countess of Chinchón is a later legend without documentary
support. In 1798 the Dutch transferred cinchona trees to Java, breaking
the Spanish monopoly on the bark, and in 1820 the French chemists
Pelletier and Caventou isolated quinine from it. Quinine then became the
standard antimalarial of the colonial era; its wider history is traced in
the history of malaria.
Medical botany therefore raises ethical and political questions. A plant
remedy could be recorded as scientific discovery after being taken from
local knowledge systems. Its value could be transformed by plantation
agriculture, imperial trade, patent medicine, or pharmaceutical chemistry.
Londa Schiebinger's study of botany in Britain and the Netherlands,
Plants and Empire, documents how colonial collecting depended on
enslaved and Indigenous labor and expertise that was rarely credited.
From Specimen To Drug
Pharmacology turned botanical objects into measured substances
From the late eighteenth century, physicians and chemists began to ask
which part of a plant, in what preparation and dose, produced a reliable
effect. William Withering described digitalis from foxglove for heart
complaints in 1785; Friedrich Sertürner isolated morphine from opium in
1804; and salicylates refined from willow bark became aspirin in 1899.
Extraction and standardization changed the relationship between plant,
dose, and drug: the same remedy could now be a dried leaf, a tincture, a
purified alkaloid, or a tablet, and those were not identical medical
objects.
Later drug research continued to draw on botanical leads. In the 1970s,
working in a Chinese state-sponsored program,
Tu Youyou's team isolated artemisinin
from Artemisia annua, guided by a fourth-century Chinese text —
Ge Hong's Zhouhou Beiji Fang (c. 340 CE) — that described a
cold-water preparation of the plant; the discovery earned the 2015 Nobel
Prize in Physiology or Medicine. The point is not that old remedies
simply became modern drugs, but that institutions changed how plant
knowledge was tested, owned, and circulated.
Plant-derived products remain widely used today. The WHO's 2019 global
report, drawing on 179 member states, documented how deeply traditional
and herbal medicine is embedded in health systems worldwide, and modern
regulation now distinguishes between whole-plant traditional products and
isolated plant-derived drugs.
- c. 300 BCE: Theophrastus's Historia Plantarum becomes the first systematic account of plant description in the Western tradition.
- c. 78 CE: Dioscorides's De materia medica becomes the central reference for medicinal plants in later Mediterranean, Islamic, and European traditions.
- 1542: Fuchs's De historia stirpium pairs printed images with descriptions drawn from living specimens.
- 1543–1545: the physic gardens at Pisa and Padua make plant teaching public and institutional.
- 1590–1621: gardens at Leiden and Oxford extend the model across Europe.
- 1640: Parkinson's Theatrum Botanicum consolidates the illustrated plant book in English.
- 1678–1693: the twelve-volume Hortus Indicus Malabaricus documents plants and medical knowledge from Malabar.
- 1703–1704: John Ray's Historia Plantarum advances the genus-and-species framework.
- 1753: Linnaeus's Species Plantarum applies binomial nomenclature consistently; the date became the starting point for modern botanical nomenclature.
- 1785–1820: Withering's digitalis, Sertürner's morphine, and the isolation of quinine mark the shift from whole plants to measured plant drugs.
- 1972: Tu Youyou's team isolates artemisinin from Artemisia annua, linking a fourth-century Chinese text to modern antimalarial therapy.